Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beatrice Labella

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Frontiers in Neurology|October 23, 2023
Hereditary transthyretin amyloidosis: a comprehensive review with a focus on peripheral neuropathyLoris Poli, Beatrice Labella, Stefano Cotti Piccinelli, et al.
Journal of Clinical Medicine|August 12, 2023
Prognostic Usefulness of Motor Unit Number Index (MUNIX) in Patients Newly Diagnosed with Amyotrophic Lateral SclerosisBarbara Risi, Stefano Cotti Piccinelli, Stefano Gazzina, et al.
Biomolecules|September 28, 2023
A Comprehensive Update on Late-Onset Pompe DiseaseBeatrice Labella, Stefano Cotti Piccinelli, Barbara Risi, et al.
Brain Sciences|August 26, 2023
Juvenile-Onset Recurrent Rhabdomyolysis Due to Compound Heterozygote Variants in the <i>ACADVL</i> GeneBeatrice Labella, Gaetana Lanzi, Stefano Cotti Piccinelli, et al.
Biomedicines|September 28, 2023
Leprosy Neuropathy in a Non-Endemic Area: A Clinical and Pathological StudyStefano Cotti Piccinelli, Matteo Tagliapietra, Tiziana Cavallaro, et al.
Brain Sciences|November 27, 2024
Gold Coast Criteria in ALS Diagnosis: A Real-World ExperienceLucia Ferullo, Barbara Risi, Filomena Caria, et al.
Muscle & Nerve|May 29, 2026
Psychosocial Determinants of Pain in Muscle BiopsyBeatrice Labella, Emmanuelle Lacene, Maud Beuvin, et al.
Journal of Medical Case Reports|February 20, 2025
SELENON-related myopathy as a cause of acute respiratory failure in middle age: a case reportBarbara Risi, Filomena Caria, Simona Damioli, et al.
Neurology and Therapy|August 2, 2025
Assessing the Safety and Efficacy of Lamotrigine as Anti-myotonic Agent in Myotonic Dystrophy Type 1 (DM1): A Longitudinal, Open-Label, Pilot StudyBarbara Risi, Nesaiba Ait Allali, Stefano Cotti Piccinelli, et al.
Scientific Reports|August 15, 2025
Extensive digital health technology assessment detects subtle motor impairment in mild and asymptomatic Pompe diseaseAndrea Pilotto, Beatrice Labella, Andrea Rizzardi, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Frontiers in Neurology|October 23, 2023
Hereditary transthyretin amyloidosis: a comprehensive review with a focus on peripheral neuropathyLoris Poli, Beatrice Labella, Stefano Cotti Piccinelli, et al.
Journal of Clinical Medicine|August 12, 2023
Prognostic Usefulness of Motor Unit Number Index (MUNIX) in Patients Newly Diagnosed with Amyotrophic Lateral SclerosisBarbara Risi, Stefano Cotti Piccinelli, Stefano Gazzina, et al.
Biomolecules|September 28, 2023
A Comprehensive Update on Late-Onset Pompe DiseaseBeatrice Labella, Stefano Cotti Piccinelli, Barbara Risi, et al.
Brain Sciences|August 26, 2023
Juvenile-Onset Recurrent Rhabdomyolysis Due to Compound Heterozygote Variants in the <i>ACADVL</i> GeneBeatrice Labella, Gaetana Lanzi, Stefano Cotti Piccinelli, et al.
Biomedicines|September 28, 2023
Leprosy Neuropathy in a Non-Endemic Area: A Clinical and Pathological StudyStefano Cotti Piccinelli, Matteo Tagliapietra, Tiziana Cavallaro, et al.
Brain Sciences|November 27, 2024
Gold Coast Criteria in ALS Diagnosis: A Real-World ExperienceLucia Ferullo, Barbara Risi, Filomena Caria, et al.
Muscle & Nerve|May 29, 2026
Psychosocial Determinants of Pain in Muscle BiopsyBeatrice Labella, Emmanuelle Lacene, Maud Beuvin, et al.
Journal of Medical Case Reports|February 20, 2025
SELENON-related myopathy as a cause of acute respiratory failure in middle age: a case reportBarbara Risi, Filomena Caria, Simona Damioli, et al.
Neurology and Therapy|August 2, 2025
Assessing the Safety and Efficacy of Lamotrigine as Anti-myotonic Agent in Myotonic Dystrophy Type 1 (DM1): A Longitudinal, Open-Label, Pilot StudyBarbara Risi, Nesaiba Ait Allali, Stefano Cotti Piccinelli, et al.
Scientific Reports|August 15, 2025
Extensive digital health technology assessment detects subtle motor impairment in mild and asymptomatic Pompe diseaseAndrea Pilotto, Beatrice Labella, Andrea Rizzardi, et al.
Pageof 2